SCHEMBL14085250

SCHEMBL14085250

BCc1ccccc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8150884 0.78 APOBEC3G (0.39) —
SCHEMBL11152568 0.78 — —
SCHEMBL3982856 0.78 — —
SCHEMBL31262371 0.77 GAA (0.44) —
SCHEMBL11150455 0.77 GAA (0.44) —
SCHEMBL36019 0.77 CYP3A4 (0.53) —
SCHEMBL29373097 0.77 CYP3A4 (0.53) —
SCHEMBL234864 0.77 CYP3A4 (0.53) —
SCHEMBL1759362 0.74 CYP3A4 (0.50) —
Ammonia Solution, Strong SCHEMBL9517239 0.74 CYP3A4 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417063-B2 Bicyclic heterocycles useful as serine protease inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-08-26 — — US disclosed
Send feedback